03.08.2013 Views

Androgens in Health and Disease.pdf - E Library

Androgens in Health and Disease.pdf - E Library

Androgens in Health and Disease.pdf - E Library

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 4/Dihydrotestosterone <strong>and</strong> 5α-Reductase 77<br />

4 Dihydrotestosterone <strong>and</strong> 5α-Reductase<br />

Normal Physiology <strong>and</strong> Inhibition<br />

Paul R. Sutton, MD, PhD, John K. Amory, MD,<br />

<strong>and</strong> Richard V. Clark, MD, PhD<br />

CONTENTS<br />

DIHYDROTESTOSTERONE IN EMBRYOGENESIS AND NORMAL ADULT<br />

PHYSIOLOGY<br />

INHIBITION OF 5α-REDUCTASE<br />

SUMMARY<br />

REFERENCES<br />

DIHYDROTESTOSTERONE IN EMBRYOGENESIS<br />

AND NORMAL ADULT PHYSIOLOGY<br />

In man, 4–8% of testosterone (T) undergoes 5α-reduction, result<strong>in</strong>g <strong>in</strong> the formation<br />

of the potent <strong>and</strong>rogen dihydrotestosterone (DHT). DHT plays a crucial role <strong>in</strong> the<br />

formation of the external male genitalia <strong>and</strong> prostate dur<strong>in</strong>g fetal life. In the adult,<br />

however, DHT is associated with a variety of chronic conditions, <strong>in</strong>clud<strong>in</strong>g benign<br />

prostatic hyperplasia, <strong>and</strong>rogenic alopecia, acne vulgaris, <strong>and</strong>, perhaps, carc<strong>in</strong>oma of the<br />

prostate—mak<strong>in</strong>g <strong>in</strong>hibition of DHT production an attractive target for pharmacotherapy.<br />

This chapter will review the role of DHT <strong>in</strong> normal development dur<strong>in</strong>g fetal<br />

life as well as its functions <strong>in</strong> the adult. We will also discuss pharmaceutical means of<br />

reduc<strong>in</strong>g DHT synthesis <strong>in</strong> the treatment of DHT-dependent diseases, with particular<br />

emphasis on the emergence of the new class of 5α-reductase <strong>in</strong>hibitors.<br />

DHT Metabolism<br />

DHT is produced by 5α-reduction from the 4–8 mg of testosterone produced daily by<br />

the adult male testes (1). Four to eight percent of this T is 5α-reduced to DHT—mostly<br />

<strong>in</strong> <strong>and</strong>rogen-responsive organs. Approximately 50 µg of DHT is produced from 5αreduction<br />

with<strong>in</strong> the testes, whereas production <strong>in</strong> other tissues is approx 300 µg daily.<br />

Circulat<strong>in</strong>g serum DHT levels are 30–86 ng/dL (1.0–2.9 nmol/L) <strong>in</strong> normal men (2,3).<br />

Tissue DHT levels with<strong>in</strong> <strong>and</strong>rogen-dependent organs are many times higher than<br />

DHT concentrations <strong>in</strong> circulat<strong>in</strong>g plasma. In the prostate, for example, tissue DHT<br />

concentrations are 10 times higher than plasma concentrations (4–6). Intraprostatic T<br />

From: Contemporary Endocr<strong>in</strong>ology: <strong>Androgens</strong> <strong>in</strong> <strong>Health</strong> <strong>and</strong> <strong>Disease</strong><br />

Edited by: C. Bagatell <strong>and</strong> W. J. Bremner © Humana Press Inc., Totowa, NJ<br />

77

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!